The widely available diabetes drug metformin reduced serious outcomes by more than half if started within 4 days of COVID symptoms in a large, randomized, double blind controlled trial, the University of Minnesota announced today. The results were published Aug. 18 in the New England Journal of Medicine.
Metformin drastically reduces COVID hospitalization
August 23, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022